SelectScience InterviewsDrug discovery > Lead Discovery
A mid-down strategy for the mass spectrometric sequencing of progressively larger nucleic acids
29 Nov 2022
Watch this presentation by Dr. Dan Fabris, Harold S. Schwenk Sr. Distinguished Chair in Chemistry, University of Connecticut, titled: A mid-down strategy for the mass spectrometric sequencing of progressively larger nucleic acids. This talk was presented at the SelectScience® Virtual Biopharmaceuticals Summit 2022.